US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 471.110
  • +3.110+0.66%
Close Sep 9 16:00 ET
  • 471.110
  • 0.0000.00%
Post 20:01 ET
121.59BMarket Cap-237934P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.66B
2.65B
-19.35M
Miss Est.
+6.89%
+6.11%
-0.73%
EPS
-12.71
-13.92
-1.21
Miss Est.
-461.16%
-495.45%
-9.50%
Analyst Rating
Buy

Sep 9, 2024

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 24 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.752B--
--2024/Q3-- / 2.691B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.752B--
--2024/Q3-- / 2.691B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

  • Vertex Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 2 16:06 ET

  • Vertex Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 16:50 ET

  • Vertex Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 15 16:20 ET

  • Vertex Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 9, 2024

    Buy

    • Buy

      73.68%

    • Hold

      15.79%

    • Sell

      10.53%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Gene Editing
    Gene Editing
    Intraday+0.57%